Founder’s June Sale at SciSparc Raises Red‑Flag Questions About Future Direction
Insider sale by SciSparc founder Shrem Itschak sparks debate on future outlook – analyze the 462‑share move and its impact on the biotech’s pipeline, cash flow and potential funding plans.
3 minutes to read